News

New April PBS Pricing

The confirmed new prices for 01 April 2014 as part of the expanded and accelerated price disclosure main cycle have been published on the Pharmaceutical Benefits Scheme (PBS) website.

The biggest cut was to docetaxel injection, which saw an almost 90% cut. The confirmed prices show this was a reduction from an approved ex-manufacturer price of $479.17 down to $48.11 (Oncotaxel 140).

Another significant price cut was topotecan, down by 56%, from $330.40 to $145.77. Fludrabine injection was cut by 48% which the published prices show was down from $103.11 to $53.87.

Click here to view the confirmed prices

Source: pharmacydaily.com.au, Wednesday 12 March 2014